Amgen Inc.
Biological Products, (No Diagnostic Substances)
- Revenue, 2025
- $36.75B
- Employees
- 17,900
- Industry
- Biological Products, (No Diagnostic Substances) (SIC 2836)
- Institutional holders
- 3,146 at 30 Jun 2026 (3,145 the quarter before)
- SEC number
- 318154
- LEI
- 62QBXGPJ34PQ72Z12S66
Source: SEC EDGAR filings and company facts, SEC Form 13F; checked 27 Oct 2026
Amgen Inc. is an American multinational biopharmaceutical company in pharmaceutical industry, headquartered in Thousand Oaks, founded in 1980.
Source: Wikidata
Source: SEC EDGAR
A free account opens 10 full pages a month and lets you follow this page: 12 quarters of figures, every filing and document, earnings call transcripts, holders and ownership changes, the Brain's cards and graph, exports to Excel.
Research from public records, not investment advice. Tamarly holds no investment positions. By reading these pages you accept the Terms of Use; figures can be late or wrong, so check the linked source before relying on one. Terms and policies.